[Behavior of some factors in the blood-clotting system and blood fibrinolytic activity in women with uterine myoma treated with progetest (Polfa)].
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D005165:Factor V / Q000378:metabolism; D005167:Factor VII / Q000378:metabolism; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009214:Myoma / Q000097:blood / Q000188:drug therapy; D011374:Progesterone / Q000494:pharmacology* / Q000627:therapeutic use; D013739:Testosterone / Q000494:pharmacology* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy
D013739:Testosterone; D011374:Progesterone; D005165:Factor V; D005167:Factor VII
Zachowanié sie niektórych czynników układu krzepniecia i aktywności fibrynolitycznej krwi u kobiet z mieśniakami macicy leczonych progestestem firmy "Polfa".